Which type of insulin is commonly recommended for the emergency treatment of DKA?

Short-acting insulin is commonly recommended for the emergency treatment of Diabetic Ketoacidosis (DKA) due to its rapid onset of action, which allows for the quick control of blood glucose levels. In a DKA situation, patients typically have very high blood sugar levels, and immediate intervention is crucial. Short-acting insulin can effectively lower blood glucose quickly, which is essential in addressing the severe hyperglycemia associated with DKA.

Moreover, the characteristics of short-acting insulin—such as its peak effect occurring within a short timeframe—make it a preferred choice in emergency settings where swift intervention is necessary. Long-acting insulin, while beneficial for routine management of diabetes, does not act quickly enough to handle the acute elevation of blood glucose in DKA. Intermediate-acting insulin shares a similar limitation due to its relatively slower onset and longer duration compared to short-acting types. Insulin pumps can be useful in ongoing management but are not typically employed during the acute emergency period of DKA, where rapid adjustments are required.